JAK2 mutations in myeloproliferative disorders [4] (multiple letters)

New England Journal of Medicine

Volumn 353, Issue 13, 2005, Pages 1416-1417

  Tefferi, Ayalew ^a   Lasho, Terra L ^a   Gilliland, Gary ^b   Kralovics, Robert ^c   Cazzola, Mario ^d   Skoda, Radek C ^c  

^a MAYO CLINIC   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; DNA; JANUS KINASE 2;

ALLELE; BLOOD; BONE MARROW CELL; CELL FRACTIONATION; CELL POPULATION; CELL PROLIFERATION; CLONE; DISEASE COURSE; DISOMY; GENE MUTATION; GENETIC SCREENING; GRANULOCYTE; HEMATOCRIT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMOZYGOSITY; HUMAN; LETTER; MEDICAL RECORD; MITOTIC RECOMBINATION; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPOIESIS; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTHEMIA; WILD TYPE;

CLONE CELLS; DNA MUTATIONAL ANALYSIS; EVOLUTION, MOLECULAR; HOMOZYGOTE; HUMANS; JANUS KINASE 2; LOSS OF HETEROZYGOSITY; MYELOFIBROSIS; POINT MUTATION; POLYCYTHEMIA VERA; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; THROMBOCYTOSIS;

EID: 25444516768     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMc051878     Document Type: Letter

References (0)